BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
OCT Clinical will be represented by our Head of Business Development Anna Yanaeva. Please, contact Anna to arrange a meeting and discuss your clinical study options: ayanaeva@oct-clinicaltrials.com
